Hospital-acquired venous thromboembolism among critically ill children with diabetic ketoacidosis: A single-center experience
Journal of Pediatric Critical Care · 2026-07 · 13 (4) · 229-234
DOI: 10.4103/jpcc.jpcc_148_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Critical Care, online erschienen am 13.08.2026. Verfasst von Kristin DeMayo und 5 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe, Kinderkrankenpflege
Abstract (Originalsprache)
Hospital-acquired venous thromboembolism (HA-VTE) rates and risk factors unique to critically ill children with diabetic ketoacidosis (DKA) are poorly described. We aimed to characterize the degree of acidosis, hyperglycemia, dehydration, and impaired mentation at presentation among children with DKA with and without subsequent HA-VTE development. In a single-center retrospective cohort study, we estimated the HA-VTE rate among children
Zitieren
APA
DeMayo, K., Havlicek, E., Root, M., Goldman, Z., Goldenberg, N., & Sochet, A. (2026). Hospital-acquired venous thromboembolism among critically ill children with diabetic ketoacidosis: A single-center experience. Journal of Pediatric Critical Care, 13(4), 229-234. https://doi.org/10.4103/jpcc.jpcc_148_25
Vancouver
DeMayo K, Havlicek E, Root M, Goldman Z, Goldenberg N, Sochet A. Hospital-acquired venous thromboembolism among critically ill children with diabetic ketoacidosis: A single-center experience. Journal of Pediatric Critical Care. 2026;13(4):229-234. doi:10.4103/jpcc.jpcc_148_25
BibTeX
@article{DeMayo2026,
author = {DeMayo, Kristin and Havlicek, Elizabeth and Root, Maya and Goldman, Zachary and Goldenberg, Neil and Sochet, Anthony},
title = {Hospital-acquired venous thromboembolism among critically ill children with diabetic ketoacidosis: A single-center experience},
journal = {Journal of Pediatric Critical Care},
year = {2026},
volume = {13},
number = {4},
pages = {229--234},
doi = {10.4103/jpcc.jpcc_148_25}
}
EUVIMED